Copyright © 2026 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

@article{188803,
        author = {Anita Yadav},
        title = {A Review on Impact of Quality Control and Quality Assurance in Pharmaceutical Industry and Their Limits},
        journal = {International Journal of Innovative Research in Technology},
        year = {2025},
        volume = {12},
        number = {7},
        pages = {4061-4065},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=188803},
        abstract = {The pharmaceutical industry plays a vital role in public health, and the assurance of product quality is its most fundamental responsibility. Quality Control.
(QC) and Quality Assurance (QA) are two interdependent pillars that maintain the safety, efficacy, and consistency of medicines throughout their life cycle.
This review paper explores their individual and combined roles, the regulatory framework governing them, and their practical significance in ensuring product reliability. It also highlights the limitations and challenges faced by the industry, including data intsegrity issues, technological adaptation, and compliance complexities. In addition, the paper discusses modern trends such as Quality by Design (QbD), continuous manufacturing, automation, and artificial intelligence integration in pharmaceutical quality management.
The review concludes that a proactive approach, global regulatory harmonization, and continuous improvement are essential for achieving sustained product excellence},
        keywords = {},
        month = {December},
        }